Posted on Tuesday, February 11, 2014 at 2:43 pm CST
Global Market Direct's pharmaceuticals report, "Lanthio Pharma B.V. - Product Pipeline Review - 2013" provides data on the Lanthio Pharma B.V.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 2:06 pm CST
Global Market Direct's pharmaceuticals report, "AmVac AG - Product Pipeline Review - 2013" provides data on the AmVac AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 1:44 pm CST
Global Market Direct's pharmaceuticals report, "XBiotech USA, Inc. - Product Pipeline Review - 2013" provides data on the XBiotech USA, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 1:35 pm CST
Global Market Direct's pharmaceuticals report, "Nuformix Ltd - Product Pipeline Review - 2013" provides data on the Nuformix Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 1:16 pm CST
Global Market Direct's pharmaceuticals report, "FirstString Research, Inc. - Product Pipeline Review - 2013" provides data on the FirstString Research, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 12:57 pm CST
Global Market Direct's pharmaceuticals report, "Nuron Biotech, Inc. - Product Pipeline Review - 2013" provides data on the Nuron Biotech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 12:42 pm CST
Global Market Direct's pharmaceuticals report, "CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2013" provides data on the CureFAKtor Pharmaceuticals. LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:58 am CST
Global Market Direct's pharmaceuticals report, "Armour Therapeutics Inc. - Product Pipeline Review - 2013" provides data on the Armour Therapeutics Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:39 am CST
Global Market Direct's pharmaceuticals report, "Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013" provides data on the Kuhnil Pharmaceutical Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:24 am CST
Global Market Direct's pharmaceuticals report, "Medinox, Inc. - Product Pipeline Review - 2013" provides data on the Medinox, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:17 am CST
Global Market Direct's pharmaceuticals report, "Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Concert Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:02 am CST
Global Market Direct's pharmaceuticals report, "EyeGate Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the EyeGate Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 10:49 am CST
Global Market Direct's pharmaceuticals report, "PDC Biotech GmbH - Product Pipeline Review - 2013" provides data on the PDC Biotech GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 10:25 am CST
Ranirestat (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:52 am CST
Global Markets Direct's, 'Left Ventricular Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Left Ventricular Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Left Ventricular Dysfunction. Left Ventricular Dysfunction - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:49 am CST
Global Market Direct's pharmaceuticals report, "Braasch Biotech LLC - Product Pipeline Review - 2013" provides data on the Braasch Biotech LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:47 am CST
Global Market Direct's pharmaceuticals report, "Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the Edgemont Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:06 am CST
Global Markets Direct's, 'Proteinuria - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Proteinuria. Proteinuria - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:01 am CST
Global Markets Direct's, 'Nasopharyngitis (Common Cold) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Nasopharyngitis (Common Cold), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nasopharyngitis (Common Cold). Nasopharyngitis (Common Cold) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 10, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "Acucela Inc. - Product Pipeline Review - 2013" provides data on the Acucela Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 10, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "Affibody AB - Product Pipeline Review - 2013" provides data on the Affibody AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 10, 2014 at 8:15 am CST
Global Markets Direct's, 'Ebola and Marburg Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Ebola and Marburg Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ebola and Marburg Infections. Ebola and Marburg Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 10, 2014 at 8:00 am CST
Eylea (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022
Source: Fast Market Research
Posted on Monday, February 10, 2014 at 8:00 am CST
Global Markets Direct's, 'Shigella Infections (Shigellosis) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Shigella Infections (Shigellosis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Shigella Infections (Shigellosis). Shigella Infections (Shigellosis) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 10, 2014 at 8:00 am CST
Global Market Direct's pharmaceuticals report, "Lipocine Inc. - Product Pipeline Review - 2013" provides data on the Lipocine Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research